Publishing House SB RAS:

Publishing House SB RAS:

Address of the Publishing House SB RAS:
Morskoy pr. 2, 630090 Novosibirsk, Russia



Advanced Search

The journal "Ateroskleroz"

2018 year, number 4

ATORVASTATIN LOADING DOSE BEFORE INTRACORONARY INTERVENTION PROVIDES PROTECTIVE EFFECT IN PATIENTS WITH CHRONIC ATHEROSCLEROTIC TOTAL OCCLUSION OF CORONARY ARTERIES

A.S. Ragozina1, I.V. Petrenko1,2, I.A. Urvantseva1,2, S.I. Pavlov2, K.Yu. Nikolaev3
1State-financed Оrganization Khanty-Mansi Autonomous Region - Ugra District Cardiodispensary В«Centre of Diagnosis and Cardiovascular Surgery», 628403, Surgut, Lenin аv., 69/1
2Khanty-Mansi Autonomous Region - Ugra Surgut State University, 628412, Surgut, Lenin аv., 1
3Institute of Internal and Preventive Medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RAS, 630089, Novosibirsk, Boris Bogatkov str., 175/1
Keywords: аторвастатин, хронические окклюзии коронарных артерий, эндоваскулярная реваскуляризация, протективный эффект, операционное повреждение, эхокардиография, atorvastatin, chronic total occlusions, endovascular revascularization, protective effect, perioperative damage, echocardiography

Abstract

Objective. To analyze the protective effect of atorvastatin loading dose on the reduction of myocardial injury associated with percutaneous coronary intervention, left ventricular systolic functionand exercise tolerancein patients with endovascular recanalization of chronic atherosclerotic total occlusions. Methods. 82 patients underwent recanalization. The patients in the main group ( n = 38) received a loading dose of atorvastatin 80 mg before surgery. Patients in control group ( n = 44) received 20 mg of atorvastatin. In both groups Troponin I, CF fraction of creatine phosphokinaseweremeasured, echocardiographyand veloergometer test were performed prior to surgery, 24 hours, 1 month, 1 year after the surgery. Results. There was no difference in Troponin I and CF fraction of creatine phosphokinase initial levels. In 24 hours in the main group in 3 patients (7,9 %) there was discovered moderate troponin I rising. In the control group there were 11 (25 %) patients with increasing in troponin I level in 5 and more times. CF fraction of creatine phosphokinase in control group was increased in 3 (7,9 %) patients, in the control group this parameter was increased in 16 (36,4 %) patients. In 1 month and 1 year Troponin Iand CF fraction of creatine phosphokinaselevel was normal in the both groups.There were no statistically significant changes in echocardiography parametersor exercise tolerance during the all follow-up period. Conclusion. Atorvastatin loading dose has a protective effect and prevents periprocedural myocardial injury. At the same time it doesn’t influence on central hemodynamics parameters measured by echocardiography.